Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

710 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Melanoma immunotherapy: strategies to overcome pharmacological resistance.
Trojaniello C, Vitale MG, Scarpato L, Esposito A, Ascierto PA. Trojaniello C, et al. Among authors: ascierto pa. Expert Rev Anticancer Ther. 2020 Apr;20(4):289-304. doi: 10.1080/14737140.2020.1745634. Epub 2020 Apr 6. Expert Rev Anticancer Ther. 2020. PMID: 32195606
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma.
Simeone E, Gentilcore G, Giannarelli D, Grimaldi AM, Caracò C, Curvietto M, Esposito A, Paone M, Palla M, Cavalcanti E, Sandomenico F, Petrillo A, Botti G, Fulciniti F, Palmieri G, Queirolo P, Marchetti P, Ferraresi V, Rinaldi G, Pistillo MP, Ciliberto G, Mozzillo N, Ascierto PA. Simeone E, et al. Among authors: ascierto pa. Cancer Immunol Immunother. 2014 Jul;63(7):675-83. doi: 10.1007/s00262-014-1545-8. Epub 2014 Apr 3. Cancer Immunol Immunother. 2014. PMID: 24695951 Free PMC article.
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.
Grimaldi AM, Simeone E, Giannarelli D, Muto P, Falivene S, Borzillo V, Giugliano FM, Sandomenico F, Petrillo A, Curvietto M, Esposito A, Paone M, Palla M, Palmieri G, Caracò C, Ciliberto G, Mozzillo N, Ascierto PA. Grimaldi AM, et al. Among authors: ascierto pa. Oncoimmunology. 2014 May 14;3:e28780. doi: 10.4161/onci.28780. eCollection 2014. Oncoimmunology. 2014. PMID: 25083318 Free PMC article.
Single versus combination immunotherapy drug treatment in melanoma.
Grimaldi AM, Marincola FM, Ascierto PA. Grimaldi AM, et al. Among authors: ascierto pa. Expert Opin Biol Ther. 2016;16(4):433-41. doi: 10.1517/14712598.2016.1128891. Epub 2016 Feb 6. Expert Opin Biol Ther. 2016. PMID: 26642234 Review.
Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology.
Gridelli C, Ascierto PA, Barberis MC, Felip E, Garon EB, O'brien M, Senan S, Casaluce F, Sgambato A, Papadimitrakopoulou V, De Marinis F. Gridelli C, et al. Among authors: ascierto pa. Expert Opin Biol Ther. 2016 Dec;16(12):1479-1489. doi: 10.1080/14712598.2016.1234602. Epub 2016 Sep 21. Expert Opin Biol Ther. 2016. PMID: 27650132
Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma.
Simeone E, Grimaldi AM, Festino L, Giannarelli D, Vanella V, Palla M, Curvietto M, Esposito A, Palmieri G, Mozzillo N, Ascierto PA. Simeone E, et al. Among authors: ascierto pa. Oncoimmunology. 2017 Jan 19;6(3):e1283462. doi: 10.1080/2162402X.2017.1283462. eCollection 2017. Oncoimmunology. 2017. PMID: 28405510 Free PMC article.
710 results